Understanding SARS CoV-2 biology to win COVID-19 battle

Authors

  • Cristiane Yumi Koga-Ito Institute of Science and Technology, UNESP – Univ Estadual Paulista, São José dos Campos (SP), School of Dentistry
  • Henrique Toshiaki Koga-Ito Paulista School of Medicine, Universidade Federal de São Paulo, UNIFESP.
  • Aline da Graça Sampaio Department of Environmental Engineering and Oral Biopathology Graduate Course, Institute of Science and Technology, São Paulo State University, UNESP.
  • Mariana Raquel da Cruz Vegian Department of Environmental Engineering and Oral Biopathology Graduate Course, Institute of Science and Technology, São Paulo State University, UNESP.

DOI:

https://doi.org/10.14295/bds.2020.v23i2.2245

Abstract

This review highlights the main findings on the biology of SARS CoV-2 and the strategies to combat COVID 19 pandemic. Since the initial outbreak in China on December 2019, the international scientific community joined efforts in an unprecedent public health battle. In late May 2020, 5 204 508 cases and 337 687 deaths have been reported by World Health Organization, with higher number of cases in Europe and Americas. SARS-CoV-2 was described as a novel variant from the coronavirus family and its genome was sequenced within a few months while COVID 19 quickly spread worldwide. The main cell receptor (angiotensin converting enzyme 2) was identified as involved in the invasion of host cells. As a result of the findings from cell biology, immunology and clinical studies, the pathogenesis of the virus started to be understood but it has been not fully elucidated so far. While a massive effort for the development of a vaccine is on course, preventive protocols for infection control have been proposed. Many studies on the discovering of effective therapeutic protocols have been developed, particularly on the redirection of already approved substances, but no gold standard treatment was established until now. An overview on the envisioned socioeconomic and politic impacts suggest that our society will be transformed after COVID 19 pandemia. As a result, deep changes in science, politics, socioeconomic and healthcare priorities shall appear in post-pandemia agenda.

KEYWORDS

Covid-19; Pandemic; SARS-CoV-2; Coronavirus.

 

Key-words: COVID 19, pandemia, SARS-CoV-2, coronavirus.

Downloads

Published

2020-06-12

Issue

Vol. 23 No. 2 (2020): SUPP. 2 - Dentistry and Sars-CoV-2

Section

COVID special issue

License

COPYRIGHT TRANSFER AND RESPONSIBILITY STATEMENT
 (PDF)

For all articles published in the BDS journal, copyright is retained by the authors. Articles are licensed under an open-access Creative Commons CC BY 4.0 license, meaning that anyone may download and read the paper for free. In addition, the article may be reused and quoted, provided that the original published version is cited. These conditions allow for maximum use and exposure of the work while ensuring that the authors receive proper credit. All metadata associated with published articles is released under the Creative Commons CC0 Universal Public Domain Dedication.

Before the submission, authors must obtain permission to reproduce any published material (figures, schemes, tables, or any extract of a text) that does not fall into the public domain or for which they do not hold the copyright. Permission should be requested by the authors from the copyright holder (usually the Publisher, please refer to the imprint of the individual publications to identify the copyright holder).

The authors hereby attest that the study is original and does not present manipulated data, fraud, or plagiarism. All names listed made a significant scientific contribution to the study, are aware of the presented data, and agree with the final version of the manuscript. They assume complete responsibility for the ethical aspects of the study.

This text must be printed and signed by all authors. The scanned version should be submitted as supplemental file during the submission process.